Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 6/2018

01-09-2018 | THE CUTTING EDGE: RESEARCH UPDATE

Assessing the safety of magnetic resonance imaging in cardiac device carriers

Authors: Elisa Gesu, Giorgio Colombo, Jane Victoria Moffat, Gruppo di Autoformazione Metodologica (GrAM)

Published in: Internal and Emergency Medicine | Issue 6/2018

Login to get access

Excerpt

Patients with a pacemaker (PM) or an implanted cardiac defibrillator (ICD) have an estimated 50–75% likelihood of having a clinical indication for magnetic resonance imaging (MRI) over the lifetime of their device [1]. …
Literature
1.
Levine GN, Gomes AS, Arai AE et al (2007) Safety of magnetic resonance imaging in patients with cardiovascular devices. Circulation 116:2878–2891CrossRefPubMed
2.
The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 34:2281–2329CrossRef
3.
Russo RJ, Costa HS, Silva PD et al (2017) Assessing the risks associated with MRI in patients with a pacemaker or defibrillator. N Engl J Med 376:755–764CrossRefPubMed
4.
5.
Costantino G, Montano N, Casazza G (2015) When should we change our clinical practice based on the results of a clinical study? Study endpoints. Intern Emerg Med 10(7):875–877CrossRefPubMed
Metadata
Title
Assessing the safety of magnetic resonance imaging in cardiac device carriers
Authors
Elisa Gesu
Giorgio Colombo
Jane Victoria Moffat
Gruppo di Autoformazione Metodologica (GrAM)
Publication date
01-09-2018
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 6/2018
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-018-1876-0

Other articles of this Issue 6/2018

Internal and Emergency Medicine 6/2018 Go to the issue

CE - COCHRANE'S CORNER

A novel flash glucose monitoring system in patients with diabetes mellitus type 1 and 2: which are the pieces of evidence for payer decision-makers?

CE - MEDICAL ILLUSTRATION

Esophago-pericardial fistula with development of hydro-pneumo-pericardium resulting in hemodynamic instability: an unusual complication of esophageal cancer

EM - ORIGINAL

Non-urgent use of emergency departments: populations most likely to overestimate illness severity

CE - LETTER TO THE EDITOR

Prognostic influence of prior chronic obstructive pulmonary disease in patients admitted for the first time because of acute heart failure: reply

IM - ORIGINAL

Ideal cardiovascular health among Ghanaian populations in three European countries and rural and urban Ghana: the RODAM study

IM - COMMENTARY

Weight-loss supplementation and acute liver failure: the case of Garcinia Cambogia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits